Business
TempraMed Signs Exclusive Commercial Distribution Agreement with Leading Distributor to the Turkish Market
Dolfin is a well-established, diversified distributor with broad reach across healthcare, hospitals, emergency services, and consumers provides strong potential for VIVI products to gain tractionTurkey is one of the highest-prevalence diabetes countries in Europe due to obesity rates, diet, urbanization, and low screening complianceOne of many distribution agreements in pipeline for Europe as part of TempraMed's defined, strategic expansion strategy Vancouver, British Columbia--(Newsfile Corp. -
About this update from Tempramed Technologies Ltd.
[{"type":"list","items":[{"val":[{"type":"text","content":"Dolfin is a well-established, diversified distributor with broad reach across healthcare, hospitals, emergency services, and consumers provides strong potential for VIVI products to gain traction","length":195,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Turkey is one of the highest-prevalence diabetes countries in Europe due to obesity rates, diet, urbanization, and low screening compliance","length":139,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"One of many distribution agreements in pipeline for Europe as part of TempraMed's defined, strategic expansion strategy ","length":123,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":457,"olType":false},{"type":"text","content":"Vancouver, British Columbia--(Newsfile Corp. - December 2, 2025) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) ("TempraMed" or the "Company"), an innovator in smart temperature-controlled medical devices, is pleased to announce that it has entered into a definitive exclusive distribution agreement with Dolfin Sağlık Ürünleri ("Dolfin Sağlık") to market and sell TempraMed's "VIVI" line of medication temperature-stabilizing products throughout Turkey.","length":509,"tagName":"p"},{"type":"text","content":"Founded in 2002, Dolfin Sağlık is one of Turkey's most recognized and trusted medical device and supplies companies. The firm serves a wide range of healthcare stakeholders including leading public and private hospitals, emergency/ambulance services, educational institutions, provincial health directorates,. Dolfin Sağlık has established a national presence built on reliability, customer service, and technological innovation, while delivering premium medical solutions across the country.","length":496,"tagName":"p"},{"type":"text","content":"Turkey is one of the highest-prevalence diabetes countries in Europe due to obesity rates, diet, urbanization, and low screening compliance. The Turkish diabetes market represents a significant commercialization opportunity for TempraMed. Approximately 10 million people in Turkey live with diabetes, with an estimated over 1 million patients using insulin[1] and additional number GLP-1 users. A large proportion of these patients depend on temperature-sensitive medic...